Comparison of the expression of ABH/Lewis-related antigens in polypoid and non-polypoid growth types of colorectal carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 2, 2001, Pages 176-183

  Nakagoe, Tohru ^a   Fukushima, Kiyoyasu ^b   Nanashima, Atsushi ^a   Sawai, Terumitsu ^a   Tsuji, Takashi ^a   Jibiki, Masa Aki ^a   Yamaguchi, Hiroyuki ^a   Yasutake, Toru ^a   Ayabe, Hiroyoshi ^a   Matuo, Tatsuki ^c   Tagawa, Yutaka ^d  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Prefecture Tarami Hospital   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

ABH isoantigens; Blood group antigen; Colorectal carcinoma; Lewis related antigens; Non polypoid growth type; Polypoid growth type

Indexed keywords

BLOOD GROUP ABH ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER CLASSIFICATION; CANCER GROWTH; COLORECTAL CARCINOMA; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035102335     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02425.x     Document Type: Article

References (36)

1. Early colorectal carcinoma with special reference to its development de novo
2. Polypoid growth and K-ras codon 12 mutation in colorectal cancer
3. The problem of de novo colorectal carcinoma
4. Flat and depressed colonic neoplasms: A prospective study of 1000 colonoscopies in the UK
5. Frequency of early colorectal cancer in patients undergoing colonoscopy
6. Relationship between morphological diversity and AgNORs or cathepsin B expression in colorectal cancers
7. Quantitative analysis of numerical chromosome aberrations in various morphological types of colorectal carcinomas
8. Aberrant glycosylation in cancer cell membranes as focused on glycolipids. Overview and perspective
9. Cell surface carbohydrates as prognostic markers in human carcinomas
10. Tumor-associated carbohydrate antigens
11. Expression of blood-group antigen A - A favorable prognostic factor in non-small-cell lung cancer
12. Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas
13. Hybridomas specific for carbohydrates; synthetic human blood group antigens for the production, selection, and characterization of monoclonal typing reagents
14. Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract
15. Histochemical demonstration of sugar residues by lectin and immunocytochemical techniques for blood group antigens in human colon
16. Characterization of sialosylated Lewisx as a new tumor-associated antigen
17. a antigens in human lung carcinoma
18. Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodies
19. a for serological tests of cancer
20. Immunohistochemical expression of ABH/Lewis-related antigens in primary breast carcinomas and metastatic lymph node lesions
21. Differences in clinical significance of blood group antigens A, B, and H in carcinoma tissue in the uterine cervix
22. Nonparametric estimation from incomplete observation
23. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
24. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival cirrhotics
25. Growth patterns of colorectal carcinoma and mucin property of transitional mucosa
26. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis
27. Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma
28. Expression of A, B, and H blood group antigens in epithelial ovarian cancer: Relationship to tumor grade and patient survival
29. b in human normal, fetal, and malignant colonic tissue
30. x antigen in liver metastases of human colorectal carcinoma
31. x antigen in relation to survival of patients with colorectal carcinoma
32. x
33. x determinant on myeloid and tumor cells